MESO TV: Sacituzumab targeting TROP-2 for mesothelioma

Our Patient Services Director, Julie White, RN, BSN, OCN, sits down with Michael Offin, MD to discuss a clinical trial . Dr. Offin is a Thoracic Medical Oncologist at Memorial Sloan Kettering Cancer Center. They discuss a current clinical trial for mesothelioma.

Our Sponsors

MesoTV is a program by The Mesothelioma Foundation. This program is made possible by our generous sponsors: Belluck Law, Dean Omar Branham Shirley, LLP;
Maune Raichle Hartley French & Mudd, LLC (MRHFM); Merck; Bristol Myers Squibb; The Gori Law Firm

Search our previous episodes for topics/speakers of interest to you at www.curemeso.org/mesotv.

Related Updates & Resources